Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Ameren $586.5 million stock offering and forward sale agreements
The shares are listed on the NYSE
Somnigroup International $953 million secondary offering
The shares are listed on the New York Stock Exchange
Middlesex Water $110 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Primo Brands $1.5 billion secondary offering
The shares are listed on the New York Stock Exchange
NOVAGOLD $243.8 million upsized public offering and concurrent private placement
The shares are listed on the New York Stock Exchange American and the Toronto Stock Exchange
Strategy $21 billion at-the-market offering
The stock is listed on the Nasdaq Global Select Market
Great Elm Capital up to $100 million at-the-market offering
We advised the company on the stock offering
Haleon $3.1 billion secondary placing of ordinary shares
The private placement included 617,553,920 ordinary shares